The effect of arabinoxylooligosaccharides on upper gastroduodenal motility and hunger ratings in humans

Autor: Kristin Verbeke, Eveline Deloose, Emidio Scarpellini, Willem F. Broekaert, Rita Vos, IE Francois, Jan A. Delcour, Jan Tack

BACKGROUND AND AIMS: Prebiotics such as Arabinoxylooligosaccharides (AXOS) are non-digestible, fermentable food ingredients stimulating growth/activity of colonic bacteria with enhanced carbohydrates fermentation (CF) in humans. The migrating motor c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac89813d36fd047a8b3bbab22a4ba271
https://lirias.kuleuven.be/handle/123456789/630905

The effect of arabinoxylooligosaccharides on gastric sensory-motor function and nutrient tolerance in man.

Autor: Scarpellini E; TARGID, Department of Internal Medicine, Division of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium., Deloose E; TARGID, Department of Internal Medicine, Division of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium., Vos R; TARGID, Department of Internal Medicine, Division of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium., Francois IE; Laboratory of Food Chemistry and Biochemistry & Leuven Food Science and Nutrition Research Centre (LFoRCe), Catholic University of Leuven, Leuven, Belgium., Delcour JA; FUGEIA NV, Arenberg Science Park, Leuven, Belgium., Broekaert WF; FUGEIA NV, Arenberg Science Park, Leuven, Belgium., Verbeke K; TARGID, Department of Internal Medicine, Division of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium., Tack J; TARGID, Department of Internal Medicine, Division of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium.

Publikováno v: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society [Neurogastroenterol Motil] 2016 Aug; Vol. 28 (8), pp. 1194-203. Date of Electronic Publication: 2016 May 20.

Fungal sphingolipids as targets for the development of selective antifungal therapeutics.

Autor: Thevissen K; Centre of Microbial and Plant Genetics, Katholieke Universiteit Leuven, Kasteelpark Arenberg 20, B-3001 Heverlee, Belgium. karin.thevissen@biw.kuleuven.be, Francois IE, Aerts AM, Cammue BP

Publikováno v: Current drug targets [Curr Drug Targets] 2005 Dec; Vol. 6 (8), pp. 923-8.